COMMUNIQUÉS West-GlobeNewswire

Motif Bio to present at upcoming investor and scientific conferences

19/03/2018 - 08:00

NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announces that the Company will present at [...]

VALNEVA Reports Positive Phase I Interim Results for Its Lyme Vaccine Candidate VLA15

19/03/2018 - 07:01

Valneva Reports Positive Phase I Interim Results for Its Lyme Vaccine Candidate VLA15 Phase I study (VLA15-101) primary endpoint met No safety concerns associated with VLA15 in any treatment group Encouraging [...]

VALNEVA publie des résultats intermédiaires de Phase I positifs pour son candidat vaccin contre la maladie de Lyme VLA15

19/03/2018 - 07:01

Valneva publie des résultats intermédiaires de Phase I positifs pour son candidat vaccin contre la maladie de Lyme VLA15 Critère d'évaluation principal de l'étude de Phase I (VLA15-101) atteint Aucun problème de [...]

MDxHealth (R): SelectMDx Liquid Biopsy Test for Prostate Cancer included in the 2018 European Association Urology Guidelines

19/03/2018 - 07:01

NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION A significant milestone in MDxHealth's strategy to increase adoption of SelectMDx ® HERSTAL, BELGIUM and IRVINE, CA - 07:00 CEST, March 19, 2018 - MDxHealth SA ( [...]

MDxHealth (R) : Le test de biopsie liquide SelectMDx® pour le cancer de la prostate est inclus dans les directives 2018 de l'Association Européenne d'Urologie

19/03/2018 - 07:01

COMMUNIQUÉ DE PRESSE INFORMATION RÉGLEMENTÉE INFORMATION PRIVILEGIEE Une étape clé dans la stratégie de MDxHealth visant à accroître l'utilisation de SelectMDx HERSTAL, BELGIQUE et IRVINE, CA - 07 :00 CEST, le 19 mars [...]

Addex Shareholders Approved all Board Proposals at Extraordinary General Meeting

19/03/2018 - 07:01

Geneva, Switzerland, 19 March 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that its shareholders approved all the proposals of [...]

Idorsia issues invitation to 2018 Annual General Meeting of Shareholders

19/03/2018 - 07:01

Allschwil, Switzerland - March 19, 2018 - Idorsia Ltd (SIX: IDIA) today issued the formal invitation to the upcoming Annual General Meeting (AGM) of Shareholders on behalf of the Board of Directors. The meeting to [...]

Strongbridge Biopharma plc Announces Presentation of New Data Demonstrating That Levoketoconazole is a Potent Inhibitor of Human Enzymes Controlling Cortisol Synthesis

18/03/2018 - 19:00

~ Data Suggest Levoketoconazole, the Isolated 2S,4R Enantiomer of Ketoconazole, Accounts for Essentially All of the Inhibition by Ketoconazole of Cortisol Biosynthesis in Humans ~ ~ Results Presented at ENDO 2018, the [...]

Radius Health Presents Positive Data for the ACTIVExtend BMD Responder Analysis for TYMLOS™ (abaloparatide) Injection at ENDO 2018 Annual Meeting

17/03/2018 - 17:30

WALTHAM, Mass., March 17, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq: RDUS ), a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative [...]

Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights

16/03/2018 - 22:10

NEW YORK and CLEVELAND, March 16, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ: ABEO ), a leading clinical-stage biopharmaceutical company focused on developing novel cell and gene therapies for life- [...]

Matinas BioPharma Appoints Jerome D. Jabbour as Chief Executive Officer and Provides Corporate Update

16/03/2018 - 22:00

Leadership appointment positions Company for next stage of value creation Successful outcome of meeting with FDA provided important insight and clarity for clinical development path forward for MAT2203 Conference call [...]

DBV Technologies Announces Filing of 2017 "Document de Référence" and 2017 Annual Report on Form 20-F

16/03/2018 - 21:31

Montrouge, France, March 16, 2018 DBV Technologies Announces Filing of 2017 "Document de Référence" and 2017 Annual Report on Form 20-F DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT) [...]

DBV Technologies Publie son Document de Référence 2017 et son «Form 20-F» américain

16/03/2018 - 21:31

Montrouge, France, le 16 mars, 2018 (21:30 CET) DBV Technologies Publie son Document de Référence 2017 et son «Form 20-F» américain DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq : DBVT), une société [...]

Reata Selected to Present Early-Stage Programs at the BIO Asia International Conference

16/03/2018 - 21:15

IRVING, Texas, March 16, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (Nasdaq: RETA ) (Reata or Company), a clinical-stage biopharmaceutical company, today announced that Chief Development Officer, Keith Ward, [...]

Geron Corporation Reports Fourth Quarter and Annual 2017 Financial Results and Recent Events

16/03/2018 - 21:10

MENLO PARK, Calif., March 16, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN ) today reported financial results for the fourth quarter and year ended December 31, 2017 and recent events. Fourth Quarter and [...]

NEXSTIM PLC ENDS NEGOTIATIONS WITH POTENTIAL CHINESE PARTNER

16/03/2018 - 17:31

Company announcement, Helsinki, 16 March 2018 at 18:30 PM NEXSTIM PLC ENDS NEGOTIATIONS WITH POTENTIAL CHINESE PARTNER Nexstim Plc (NXTMH:HEX, NXTMS:STO) ("Nexstim" or "Company"), the targeted neuromodulation company [...]

Canada House Wellness Group Announces Six-Month Extension to the Term of Warrants Issued on March 13, 2015

16/03/2018 - 16:04

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 16, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“ Canada House ” or the “ Company ”) announces [...]

Progressive Care to Present at The Wall Street Investor Forum 26th Annual Investor Conference

16/03/2018 - 16:00

MIAMI, March 16, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), a healthcare services and technology company, announced today that it will be presenting at The Wall Street Investor Forum 26 th Annual [...]

Kane Biotech Schedules Fourth Quarter and Full Year 2017 Earnings Conference Call and Business Update

16/03/2018 - 15:53

WINNIPEG, Manitoba, March 16, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that it will host a conference call on Thursday, March [...]